Harald FRICKE

Follow

Person

Mannheim, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Diagnostic anti-CD95L antibody
- Patent number 10,266,600
- Issue date Apr 23, 2019
- APOGENIX AG
- Harald Fricke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of the CD95 signaling pathway for treatment of MDS
- Patent number 9,540,431
- Issue date Jan 10, 2017
- APOGENIX AG
- Harald Fricke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INHIBITORS OF THE CD95 SIGNALING PATHWAY FOR TREATMENT OF MDS
- Publication number 20170166648
- Publication date Jun 15, 2017
- APOGENIX AG
- Harald FRICKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination of CD95/CD95L inhibition and Cancer Immunotherapy
- Publication number 20170106048
- Publication date Apr 20, 2017
- APOGENIX AG
- Claudia KUNZ
- G01 - MEASURING TESTING
Information Patent Application
DIAGNOSTIC ANTI-CD95L ANTIBODY
- Publication number 20170044264
- Publication date Feb 16, 2017
- APOGENIX AG
- Harald Fricke
- G01 - MEASURING TESTING
Information Patent Application
METHOD OF DIAGNOSING CANCER
- Publication number 20160103132
- Publication date Apr 14, 2016
- Apogenix GmbH
- Harald FRICKE
- G01 - MEASURING TESTING
Information Patent Application
INHIBITORS OF THE CD95 SIGNALING PATHWAY FOR TREATMENT OF MDS
- Publication number 20150166632
- Publication date Jun 18, 2015
- Apogenix GmbH
- Harald Fricke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-4 RECEPTOR AND IL-13 AS PROGNOSTIC MARKERS FOR COLON AND PANCREA...
- Publication number 20100111969
- Publication date May 6, 2010
- Apogenix GmbH
- Harald FRICKE
- C07 - ORGANIC CHEMISTRY